Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Pyrimethamine overcomes resistance to hypomethylating agents by reducing de novo pyrimidine synthesis.
Journal: Experimental hematology
Published: May 05, 2025
Pyrimethamine overcomes resistance to hypomethylating agents by reducing de-novo pyrimidine synthesis.
Journal: Experimental hematology
Published: May 05, 2025
Ring Chromosomes in Patients with Myeloid Neoplasms Are Associated with a Poor Response to Therapy.
Journal: Acta haematologica
Published: April 17, 2025
A novel 3-way translocation involving ETV6::IL3 drives AML with eosinophilia.
Journal: Blood neoplasia
Published: October 04, 2024
Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matched multicenter cohort study.
Journal: Leukemia
Published: May 31, 2024
Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database Analysis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 12, 2024
Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights.
Journal: JCO precision oncology
Published: January 31, 2024
Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia.
Journal: American journal of hematology
Published: January 19, 2024
Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022.
Journal: Acta haematologica
Published: April 27, 2023
Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabine.
Journal: Leukemia & lymphoma
Published: November 12, 2022
Last Updated: 09/26/2026